February 28, 2019

Novocure Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Company Update

Quarterly net revenues of $69.7 million, representing 30 percent growth versus the fourth quarter 2017 and 8 percent growth versus the third quarter 2018 Full year 2018 net revenues of $248.1 million, representing annual growth of 40 percent compared to 2017 Three additional phase 3 clinical trials… Read More
learn more
February 28, 2019

Novocure Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Company Update

Quarterly net revenues of $69.7 million, representing 30 percent growth versus the fourth quarter 2017 and 8 percent growth versus the third quarter 2018 Full year 2018 net revenues of $248.1 million, representing annual growth of 40 percent compared to 2017 Three additional phase 3 clinical trials… Read More
learn more